Mealey's (October 12, 2016, 3:23 PM EDT) -- BOSTON — A federal judge did not err in dismissing a securities class action complaint against a pharmaceutical company and certain of its executive officers and directors because a shareholder failed...
Panel: Investor Failed To Plead Strong Inference Of Scienter In Securities Suit
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login